Investigating a key enzyme in tuberculosis bacteria
Protein-Derived Cofactor in Bifunctional Enzyme KatG from Mycobacterium tuberculosis
This study is looking at a special enzyme from the tuberculosis bacteria to see how a certain protein can help it fight off stress, with the goal of making the bacteria weaker and improving treatments for people with tuberculosis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas San Antonio NIH-funded |
| Lab location | 1 site (San Antonio, United States) |
| Project ID | NIH-11168868 on NIH RePORTER |
What this research studies
This research focuses on the enzyme KatG from Mycobacterium tuberculosis, which plays a crucial role in the bacteria's ability to survive in the human body. The study aims to understand how a specific protein-derived cofactor enhances the enzyme's function, particularly its ability to combat oxidative stress. By inhibiting the catalase activity of KatG, the research seeks to weaken the bacteria's virulence while simultaneously enhancing the effectiveness of existing tuberculosis treatments. This dual approach could lead to more effective therapies for tuberculosis patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with tuberculosis who may benefit from enhanced treatment options.
Not a fit: Patients with non-tuberculosis infections or those who do not respond to standard tuberculosis treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for tuberculosis, making them more effective against the bacteria.
How similar studies have performed: Previous research has shown promise in targeting bacterial enzymes to improve treatment outcomes, suggesting that this approach could be effective.
Where this research is happening
San Antonio, United States
- University of Texas San Antonio — San Antonio, United States (Active)
Researchers
- Principal investigator: Liu, Aimin — University of Texas San Antonio
- Study coordinator: Liu, Aimin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.